Article Per Year (5 Year)
p-Index From 2021 - 2026
4.801
P-Index
This Author published in this journals
All Journal Jurnal Ilmiah Farmasi The Journal of Experimental Life Sciences (JELS) Journal of Indonesian Tourism and Development Studies Biotropika Pelita Perkebunan Jurnal Pembangunan dan Alam Lestari Jurnal Farmasi Klinik Indonesia Majalah Kulit, Karet, dan Plastik Jurnal Ilmu Farmasi dan Farmasi Klinik (Journal of Pharmaceutical Science and Clinical Pharmacy) Pharmacon Journal of Tropical Biodiversity and Biotechnology INDONESIAN JOURNAL OF PHARMACY Journal of Islamic Pharmacy JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA Jurnal Farmasi Sains dan Komunitas Jurnal Biodjati Journal of Islamic Medicine JSFK (Jurnal Sains Farmasi & Klinis) PHARMACY: Jurnal Farmasi Indonesia (Pharmaceutical Journal of Indonesia) Manuju : Malahayati Nursing Journal JFIOnline J-Dinamika: Jurnal Pengabdian Kepada Masyarakat Jurnal Farmasi Higea Pharmacoscript An-Nadaa: Jurnal Kesehatan Masyarakat Pharma Xplore : Jurnal Sains dan Ilmu Farmasi ad-Dawaa : Journal of Pharmaceutical Sciences Jurnal Layanan Masyarakat (Journal of Public Service) Journal of Community Development Berkala Penelitian Hayati Jurnal Ilmiah Kesehatan (JIKA) Pharmaceutical Sciences and Research (PSR) Borneo Journal of Pharmacy Agrimas : Jurnal Pengabdian Masyarakat Bidang Pertanian Jurnal Farmasi Sains dan Terapan (Journal of Pharmacy Science and Practice) Folia Medica Indonesiana Journal of Pharmascience
Suharjono, Suharjono
Faculty Of Pharmacy, Universitas Airlangga
Agriculture, Biological Sciences & Forestry Humanities Biochemistry, Genetics & Molecular Biology Chemical Engineering, Chemistry & Bioengineering Chemistry Civil Engineering, Building, Construction & Architecture Computer Science & IT Control & Systems Engineering Decision Sciences, Operations Research & Management Earth & Planetary Sciences Education Engineering Environmental Science Health Professions Immunology & microbiology Materials Science & Nanotechnology Medicine & Pharmacology Neuroscience Nursing Public Health Social Sciences Veterinary Other

Published : 73 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 73 Documents
Search

 4   5   6   7   8 
Pemasaran E-Commerce Produk Inovasi Di Kelompok Tani Tirto Wangi Kabupaten Jember ALI, FANDYKA YUFRIZA; Pratita, Dian Galuh; Suwardi, Suwardi; Prasetyo, Hari; Rosdiana, Eva; Suharjono, Suharjono
Agrimas : Jurnal Pengabdian Masyarakat Bidang Pertanian Vol. 2 No. 1 (2023): APRIL
Publisher : Politeknik Negeri Jember

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.25047/agrimas.v2i1.29

Abstract

Kegiatan penyuluhan merupakan kegiatan yang rutin dilakukan di kalangan kelompok tani sebagai upaya dalam diseminasi ilmu pengetahuan kepada anggota kelompok tani. Kemajuan teknologi juga ikut membawa kemajuan bagi sektor pertanian termasuk kegiatan penyuluhan dengan memanfaatkan ICT (Information and Communication Technology) dalam berbagai kegiatan. Masa pandemic COVID 19 memaksa masyarakat dan seluruh sector baik komunikasi, perdangangan, Pendidikan, dan pelayanan jasa untuk ikut berlomba dengan teknologi karena seluruh kegiatan dilakukan dengan jarak jauh. Oleh karena itu kegiatan ini bertujuan melihat pengetahuan dan keterampilan penggunaan ICT dalam hal ini adalah e-commerce dan strategi pemasaran pada kelompok tani. Secara lebih spesifik kegiatan pengabdian dilakukan di Kelompok Tani Tirto Wangi Kabupaten Jember dengan metode penyuluhan dan demonstrasi secara langsung. Selain itu juga menggunakan questioner untuk melihat pengetahuan responden sebelum dan setelah dilakukan kegiatan. Anggota kelompok tani memiliki kemampuan dalam menghasilkan produk – produk inovasi sebagai factor input pertanian dengan bahan organic. Secara lebih lanjut, responden yang merupakan anggota kelompok tani tidak mengenali akan strategi pemasaran dan hanya menjual produk inovasi mereka secara langsung pada orang – orang sekitar dan kolega. Penetapan harga disesuaikan dengan biaya yang dikeluarkan dalam memproduksi suatu barang, dan promosi dilakukan hanya sekedar mensosialisasikan jika ada yang menanyakan. Sebelum dilakukan penyuluhan, para responden mulai menyadari arti penting dari strategi pemasaran yang meliputi produk, place, price, promotion. Selain itu sebelum dilakukan demonstrasi penggunaan e-commerce, para responden tidak memahami cara mengoperasikan e-commerce sebagai pelaku usaha. Demostransi sangat memberikan manfaat bagi para responden dengan respon yang sangat baik dari para responden selama kegiatan.
Germination and Early Seedling Growth of Three Arabica Coffee Varieties at Four Seed Soaking Water Temperatures Wibowo, Ari; Aprillia Wijaya, Stefani; Suharjono, .
Pelita Perkebunan (a Coffee and Cocoa Research Journal) Vol. 39 No. 1 (2023)
Publisher : Indonesian Coffee and Cocoa Research Institute

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22302/iccri.jur.pelitaperkebunan.v39i1.540

Abstract

It takes three weeks to analyze the germination percentage of Arabica coffee seeds germinated using paper and a three-day water-soaking method. This 3- week period is considered too long for seed distribution to remote areas. Thus, we need to modify this germination test needs to be modified to have a shorter test time. Temperature treatment is one method to break the seed dormancy period for faster germination. This study aimed to obtain a faster and more precise method of germination test on Arabica coffee seeds. This study employed a 3 x 4 factorial complete randomized block design with three replications in which Arabica coffee varieties of Gayo-1, Kartika-1, and Sigararutang as the first factor and the temperature of the soaking water of the seeds (25 0C, 50 0C, 75 0C, and 90 0C) as the second factor. The research was conducted at the Plant Breeding Laboratory, Indonesian Coffee and Cocoa Research Institute (ICCRI), for four months. Findings showed that the interaction between treatments was only found in seed germination percentage. Soaking in room temperature water (control) for three days was better than using water at 50 0C, 75 0C, and 90 0C on the germination percentage, sprout length, and vigor index. Observations of Arabica seed germination could be shortened to 14 days compared to the standard 21-day observation. During the seedling phase, the shoot growth and root growth of the Arabica coffee seeds soaked in water at 50 0C showed no significant difference from the control. Soaking at 75 0C and 90 0C damaged the embryo and resulted in rotten seeds. Different varieties led to different germination percentages, sprout lengths, and fresh weight of seedling shoots. The method of soaking at 50 0C for 30 minutes could be used as an alternative in germination test of Arabica coffee seeds because it showed small negative effect on germinated seed and seedling quality but it shorten thetesting time for three days.
EFIKASI DAN KEAMANAN INHIBITOR PCSK9 DALAM PENCEGAHAN STROKE ISKEMIK: LITERATURE REVIEW Shofia Ummu, Lathifa; Suharjono, Suharjono
Pharmacoscript Vol. 8 No. 1 (2025): Pharmacoscript
Publisher : Lembaga Penelitian dan Pengabdian Masyarakat, Universitas Perjuangan Tasikmalaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36423/pharmacoscript.v8i1.2047

Abstract

Stroke iskemik merupakan kelainan neurologis yang ditandai dengan berkurangnya suplai darah ke otak sehingga mengalami kekurangan oksigen dan nutrisi kemudian menjadi nekrotik. salah satu penyebab stroke iskemik yang paling umum adalah terbentuknya aterosklerosis yang dikaitkan dengan kejadian stroke berulang. Penggunaan inhibitor PCSK9 dapat diberikan sebagai terapi pencegahan stroke iskemik dan kejadian stroke berulang sehingga perlu dilakukan kajian tentang efikasi dan keamanan inhibitor PCSK9 dalam pencegahan stroke dan penurunan angka kejadian stroke berulang. Penelitian ini menggunakan metode literature review dengan pencarian artikel dibatasi pada rentang waktu antara 2013 – 2023. Inhibitor PCSK9 secara signifikan dapat menurunkan LDL-C dan trigliserida sehingga mengurangi pembentukan aterosklerosis yang merupakan penyebab utama kejadian stroke. Kesimpulannya, inhibitor PCSK9 dapat digunakan sebagai pencegahan stroke iskemik dan stroke berulang tetapi pada beberapa penelitian belum menunjukkan keamanan ditandai dengan adanya efek samping kejang dan reaksi terhadap tempat suntikan sehingga perlu dilakukan penelitian lebih lanjut.
Efektifitas dan Keamanan Terapi Sodium Glucose Co-transporter 2 (SGLT2) Inhibitor pada Gagal Jantung: Narrative Literatur Review Diniah, Melisa Nur; Suharjono, Suharjono
Jurnal Farmasi Sains dan Terapan (Journal of Pharmacy Science and Practice) Vol. 12 No. 1 (2025): March
Publisher : Faculty of Pharmacy, Widya Mandala Surabaya Catholic University, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33508/jfst.v12i1.5866

Abstract

Heart Failure (HF) is a clinical syndrome due to structural or functional defects in the myocardium causing impaired ventricular filling or ejection of blood. HF is currently divided into 3 types namely HFrEF, HFpEF, and HFmEF. In the last 5 years, treatment in HF patients has been updated to be able to use SGLT 2 inhibitor therapy. Initially, SGLT2 inhibitors were a therapy given to patients with type 2 diabetes mellitus. This recommendation was given because SGLT2 inhibitors can reduce the risk of cardiovascular death and reduce the incidence of repeated hospitalizations in HF patients. The safety of SGLT2 inhibitor administration is also reported to not cause serious side effects.
Monitoring Serum Creatinine, Blood Urea Nitrogen in Patients Brain Injury with Mannitol Therapy Sari, Erni A; Suharjono, Suharjono; Wahyuhadi, Joni
Folia Medica Indonesiana Vol. 56, No. 4
Publisher : Folia Medica Indonesiana

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Increased intracranial pressure is a further effect of brain injury due to structural damage and osmotic and water imbalances (Edema). Mannitol works in the proximal tubules and mannitol in the absorption of tubular cells by the mechanism of pinocytosis. The fluid transfer will draw fluid into the intracellular, so that the cell will be switched and broke. This phenomenon is referred to as the phenomenon of "Nephrosis Osmotic", in which mannitol administration may occur as a result of accumulation of drugs in the kidneys due to prolonged exposure to mannitol in the kidney and given dosage. The effects of osmotic diuresis occurring plus the dose and duration of mannitol administration are reported to cause renal function disorders (Scr and BUN). The aim of this study was to analyze changes in serum creatinine and BUN in patients with brain injury from before receiving mannitol therapy and during mannitol treatment. From the results of the study the number of patients who met the inclusion criteria, 32 patients. Serum creatinine, the initial average of 0.85 ± 0.17 mg / dl and the last day of the mean SCr 0.74 ± 0.30 mg / dl. While the mean BUN (Blood Urea Nitrogen) was 11.27 ± 2.75 mg / dl and the mean last day was 17.08 mg / dl ± 8.59 mg / dl. From Serum Creatinine and BUN data it can be concluded that there is no significant change.
Analysis of nacl-mannitol hydration on renal function of head and neck cancer patients receiving high-dose cisplatin chemotherapy combination Desiani, Ekanita; Suharjono, Suharjono; Yulistiani, Yulistiani; Susilo, Dwi Hari
Folia Medica Indonesiana Vol. 53, No. 1
Publisher : Folia Medica Indonesiana

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Cisplatin is one of platinum cytostatic drug for the medication of solid cancers, one of which is head and neck cancer. Adverse event that resulted during drug treatment was acute or chronic nephrotoxicity. Cisplatin concentration in proximal tubular epithelial cells is about 5 times the serum concentration. Platinum exposure on renal tubular cells bonding covalent complex which stimulate production of inflammatory factors that lead to apoptosis and necrosis cell. Cisplatin nephrotoxicity can be prevented by aggressive hydration or alternate method of administration. The aim of this study was to analyze the effectiveness of NaCl-Mannitol hydration on renal function of head and neck cancer patients receiving cisplatin 100 mg/m2 chemotherapy combination with 5FU or paclitaxel. This was a cohort, prospective, and observational study to analyze renal function of head and neck cancer patients receiving cisplatin 100 mg/m2 chemotherapy combination with 5FU or paclitaxel. Inclusion criteria were BUN 7-18 mg/dl and serum creatinine < 2 mg/dl of any cycle. All patients received infuse NaCl-Mannitol hydration with term that provided in Surgeon Departement of Dr. Soetomo General Hospital. Data obtained were BUN, SCr, and eClCr Cockroft-Gault, each was measured pre- and post-hydration. In cisplatin and 5FU chemotherapy combination value BUN pre-hydration (11,99 + 4,62) mg/dl, value BUN post-hydration (12,14 + 4,74) mg/dl and value serum creatinine pre-hydration (0,97 + 0,34) mg/dl, value serum creatinine post-hydration (1,02 + 0,37) mg/dl. Meanwhile to the combination of cisplatin and paclitaxel chemotherapy, value BUN pre-hydration (10,19 + 2,58) mg/dl, value of BUN post-hydration (10,43 + 2,31) mg/dl and value of serum creatinine post- hydration (0,98 + 0,26) mg/dl. In conclusion, NaCl-Mannitol hydration administration is adequate which is shown by BUN and serum creatinine in pre- and post-hydration data within normal limits.
Analysis of deferasirox and deferipron use in children with pediatric -thalassemia major Sutrisnaningsih, Evy Sari; Suharjono, Suharjono; Sudarmanto, Bambang
Folia Medica Indonesiana Vol. 52, No. 1
Publisher : Folia Medica Indonesiana

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

b-thalassemia major is a genetic disease and a decline in production due to imperfect of hemoglobin. Clinical manifestations are anemia, treated with regular blood transfusions. Blood transfusions lead to an increase in iron in the body that can lead to organ complications. Iron chelation drug delivery is expected to reduce complications due to an increase in the amount of iron in the body by measuring serum ferritin. The study aims to analyze the use of deferasirox and deferipron in patients with b-thalassemia major children at Dr. Kariadi Hospital of January 1, 2012 until December 31, 2013 as well as the need for blood transfusions. Patients who met the inclusion criteria, ie patients with b-thalassemia major children, retrospectively conducted observations of medical records include basic data and laboratory data. After descriptive analysis was performed to determine the use of two types of iron chelating drugs. In this study, 9 patients included in the inclusion criteria. A total of 5 people using deferasirox and 4 using deferipron at baseline. There are 3 people who turned deferipron be deferasirox. Serum ferritin values at study entry was> 1200 mcg/L, and at the end of the study serum ferritin is> 1200 mcg/L. The mean dose of deferasirox study was 19 ± 4.3 mg, and the dose deferipron mean was 80.8 ± 7.7 mg. Mean hemoglobin levels before transfusion was 6.60 ± 0.89 mg/dL. The average number of blood transfusions given was 336.52 ± 73.85 ml. Type of blood transfusion is used Washed erythrocyte. Splenomegaly occurred in 2 patients. There is no change in renal function, and hepatic meaning. The final conclusion until the reduction target serum ferritin <1000 mg/L has not been reached. Deferasirox dose can be increased to achieve the expected serum ferritin.
Nt-probnp level changes after combination therapy with bisoprolol and ace-inhibitor in patient with heart failure Risthanti, Reine Risa; Aminuddin, Muhammad; Suharjono, Suharjono
Folia Medica Indonesiana Vol. 52, No. 4
Publisher : Folia Medica Indonesiana

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Heart failure (HF) is the final common stage of many diseases of the heart. NT-proBNP levels are increased in HF and correlate well with ventricular wall stress and severity of HF. Combination therapy with Bisoprolol and ACE-inhibitor decreases NT-proBNP level in patient with HF. The use of Bisoprolol as a combination with ACE-inhibitor is still dominate in outpatient setting at Dr. Soetomo teaching hospital. The objective of this study is to analyze NT-proBNP level changes as an indicator in cardiac function after combination therapy with Bisoprolol and ACE-inhibitor in patient with HF.Methods: This study was prospective, observational and conducted in outpatient setting. Consecutive patients who meet the inclusion criteria of the study were included. Blood samples were taken at pre and 2 months post combination therapy with Bisoprolol and ACE-inhibitor, then NT-proBNP level was measured with IMMULITE®. There were 14 patients enrolled in this study (7 males, 7 females). The result showed that NT-proBNP 2 months post combination therapy with Bisoprolol and ACE-inhibitor is significantly decreased than baseline with mean baseline of NT-proBNP level is 4191.43 ± 4367.277 pg/ml to 2786.79 ± 2485.199 pg/ml (p=0.025). From a total 14 patients, 9 patients had NT-proBNP decreases >20% (20.1% – 56.4%) and 3 patients had NT-proBNP decreases <20% (1.8%, 6.6%, and 12.4%). There were 2 patients with NT-proBNP increases >40% (43.4% and 40.4%). In conclusion, there was a significant decreases in NT-proBNP level after 2 months combination therapy with Bisoprolol and ACE-inhibitor in patient with HF.
Effect of Atorvastatin in Lipid Profile Changes and Inflammation Marker TNF-alpha on Diabetes Patient with Dyslipidemia Melasari, Wulan Panduwi; Suharjono, Suharjono; Samsulhadi, Wiwid
Folia Medica Indonesiana Vol. 57, No. 1
Publisher : Folia Medica Indonesiana

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Diabetes is one of the risk factors for cardiovascular disease (CVD). Diabetics patients have 2 to 4 times increased risk of cardiovascular disease compared with non-diabetics. TNF-alpha is a proinflammatory cytokine that can be used to determine the risk of atherosclerosis complications triggered by inflammation in diabetes. Statins are a class of HMG CoA reductase inhibitors that inhibit cholesterol biosynthesis and have pleioropic effects that inhibit the release of inflammatory cytokines like TNF-alpha and stabilize atherosclerotic plaques. This study aims to determine the effect of atorvastatin 20 mg/day for 30 days in reducing the lipid profile and TNF-alpha inflammatory markers in patients with diabetes dyslipidemia. Diabetes patient with dyslipidemia who included the inclusion criteria in this observational prospective cohorts studies treated with atorvastatin for 30 days (n = 19). The efficacy of statin therapy was measured by lipid profiles (LDL, TG, HDL, and total cholesterol) and TNF-alpha. The results of the study showed that atorvastatin decreased 40.55% of LDL levels, 15.34% of TG levels, and 30.70% oftotal cholesterol levels which statistically significant (P <0.05). As for HDL, there is an increase of 6.06% but statistically non-significant (P >0.05). TNF-alpha levels increased by 11.30% which statistically non-significant (P >0.05). The use of atorvastatin 20 mg for 30 days gave reduction in LDL, TG, and total cholesterol and increased in HDL. Atorvastatin does not have a reducing effect on TNF-alpha. There was no correlation between lipid profile changes with TNF-alpha changes.
Changes on Serum Troponin T Level before and after Taking Standard Therapy Medication in Heart Failure Patients Indrawijaya, Yen Yen Ari; Suharjono, Suharjono; Aminuddin, Muhammad; Retnowati, Endang; Rahman, Gilang Mauladi
Folia Medica Indonesiana Vol. 56, No. 1
Publisher : Folia Medica Indonesiana

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Patients with advanced heart failure (NYHA FC III and IV heart failure) had positive cardiac troponin levels in previous cohort studies. In heart failure, cardiac troponin T (cTnT) is a biomarker that is sensitive to myocardial damage, especially myocardial necrosis. However, there is still little information regarding changes in cTnT levels during standard therapy. This prospective observational study is aimed at evaluating changes in cTnT levels before and after theadministration of standard therapy and evaluating symptom improvement before and after the administration of standard therapy in patients with severe heart failure. Measurement of cTnT levels and symptom improvement parameters before treatment was carried out on the first day of the inpatient and measurement after therapy was carried out on the last day of the inpatient. Sampling was done by consecutive sampling and found 30 patients in the inpatient room of the SMF Cardiovascular Disease, Dr. Soetomo Hospital, Surabaya during the months of May-July 2017. The results of the study obtained the average cTnT levels before therapy 33.48 + 31.88 pg/ml and the average cTnT levels after therapy 46.32 + 52.68 pg/ml. Based on the statistical difference test with the Wilcoxon sign-ranked test, there was no significant change in cTnT levels (p = 0.318). On the parameter of clinical symptom improvement, there was a significant decrease in pulse, respiratory rate, blood pressure, and mean arterial pressure before and after administration of therapy (p <0.05). There was no change in troponin T levels before and after the administration of therapy meant there was no worsening of myocardial necrosis.
Co-Authors A.A. Ketut Agung Cahyawan W Achmad Ridwan Achmad Ridwan, Achmad Agriawan Sudirman Ahmad Nasir ahmad, abraham Aliviyanti, Dian Andri Geger Noviantoro Anita Purnamayanti Aprillia Wijaya, Stefani Arfani, Nurfitri Ari Wibowo Arief Bachtiar Arina Dery Puspitasari Assiddiqy, Miftah Farid Bagiyo, Harry Bagiyo, Harry Bagyo Yanuwiadi Bambang Eko Wahyono Bambang Sidharta Bambang Sudarmanto Budi Suprapti Budiatin, Aniek Setya Budiatin, Aniek Setya Catur Retnaningdyah Chairunnisa Chairunnisa Chris Alderman Chrismawan A, Chrismawan A Chrismawan Ardianto Dea Ayu Nabilah Debora Shinta Liana Dewi Wara Shinta Didik Hasmono Dinda Monika Nusantara Ratri Diniah, Melisa Nur Djafar, Zaenab Dliyauddin, Moh Dwiyatna, Surya Ekanita Desiani Elvan Dwi Widyadi Emiliana Kasmudjiastuti Emy Sulistyo Astuti Endang Arisoesilaningsih Endang Retnowati Eni Susanti Faizah, Mamluatul Faizal Mustamin Fandyka Yufriza Ali Fasich Fasich Fransiska Maria Christianty Gratia, Veronica Hari Prasetyo Hasria Alang Heru Purwanto Hubby, Hubby I Gede Edy Sagitha I Ketut Mandikin Ilham Rizqy Isnain Imam Faozi Imam Susilo Indira D. Kharismawati Irfan Mustafa Irma Novrianti Irma Novrianti Irvina Harini Isnaeni Jaka Susila Jikrona, Rafi Joni Kusnadi Joni Wahyuhadi, Joni Jufri Ubrusun Junaidi Khotib Kenyo Alexandra Oktaviani Khaerani Khaerani Khusnul Fitri Hamidah Kusuma Arum Ningsih Kuwatno Kuwatno Lestiono, . Lestiono, . Lewi Tigor Simorangkir Lisa Narulita Lisa Narulita Liziyyannida Liziyyannida M. Yusuf Assegaf Mahardian R, Mahardian R Mahardian Rahmadi Mahfudz Mahfudz Makitalentu, Feybe Marcha Debby Saraswati Mareta Rindang Andarsari Masyrobatin, Masyrobatin Medina, Farah Meita Rafika Fitriani Melasari, Wulan Panduwi Mohammad Akram Muhammad Aminuddin, Muhammad Muhammad Fathoni, Muhammad Mulja Hadi Santosa Narulita, Lisa Nasir, Ahmad Neldi, Vina Nia Kurniawan Nur Afni NUR CHAKIM Nur ‘Azah Nurmainah Nurmainah Nurrofik, Agus Octaviany, Evi Paramita, Angggun Putri Paulus Sugianto Prasetyanti, Intan Kris Prastuti Asta Wulaningrum Pratita, Dian Galuh Pratiwi, Esti Rizkiana Primadi Avianto Purwanto, Diyna Rusayliya Rahman, Gilang Mauladi Rahmawati Raising Ria Rositasati Riefkah Bilal risha fillah fithria Risthanti, Reine Risa Rodiyati Azrianingsih Rosdiana, Eva Rudi Safarudin Rudi Wardana Rusdiana, Silvia Rusdiana, Silvia Safarudin, Rudi Sahayuna, Dara Demi Samirah Samirah Samirah Samirah, Samirah Samsulhadi, Wiwid Sanita Suriani Sari, Erni A Semedi S J Shafira Muti Ardiana Shahroni, Abdul Mutholib Shofia Ummu, Lathifa Simorangkir, Lewi Tigor Sindy, Sulih Probo Sinuraya, Sabarita SJ, Semedi Soemarno Soemarno Solihin, Imron Sudirman, Agriawan Sukardiman Sumarno . Sumarno Sumarno Suryadi Suryadi Susilo, Dwi Hari Sutrisnaningsih, Evy Sari Suwardi Suwardi Toetik Aryani Tri Ardyati Umami, Zahra Veronica Gratia Wanudya Atmajani WENNY PUTRI NILAMSARI Widhiati Widhiati Widyadi, Elvan Dwi Wiwid Samsulhadi Wulan Panduwi Melasari Yance Anas yance yance Yen Yen Ari Indrawijaya YOGA DWI JATMIKO Yogiarto Yogiarto Yulia Ayu Purnamasari Yulistiani Yulistiani Yulistiani Yulistiani, Yulistiani Yulistiani, . Yuniati T Yuniati T Yuniati T, Yuniati Yusfar, Yunarti Yustiana Yustiana, Yustiana Zamrotul Izzah Zulfiana, Risa